Tag: des
Onyx ONE sub-analysis shows higher cardiac death for P2Y12 inhibitor compared to aspirin following DAPT
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysis of the Onyx ONE st...
CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial
Biotronik has announced three-year data from the BIOFLOW-V trial, which were presented at the Ca...
Orsiro Mission gets CE mark
Biotronik has received CE mark certification for the Orsiro Mission drug-eluting stent (DES) sys...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based ther...
Patient recruitment reaches half-way point for global DAPT study
December marked a significant milestone for a major study into the use of short duration dual an...
Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg
New data, just published in the Journal of the American Heart Association (JAHA), suggest that t...
Medtronic releases Resolute Onyx drug-eluting stent in Japan
Medtronic will release the Resolute Onyx coronary stent system in Japan. According to a press re...
